Chronic obstructive pulmonary disease and the NICE guideline.
This article covers the key priorities identified by the National Institute for Clinical Excellence (NICE) guideline for the management of chronic obstructive pulmonary disease (COPD) and examines the role of nurses in achieving these priorities for good care of patients with COPD.
Booker
Rachel
R
National Respiratory Training Centre, Warwick. r.booker@nrtc.org.uk
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D017281:Cost of Illness; D003937:Diagnosis, Differential; D004347:Drug Interactions; D016903:Drug Monitoring; D019317:Evidence-Based Medicine; D005081:Exercise Therapy; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008875:Middle Aged; D010366:Peak Expiratory Flow Rate; D017410:Practice Guidelines as Topic; D015995:Prevalence; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D012307:Risk Factors; D016540:Smoking Cessation; D013147:Spirometry; D013806:Theophylline / Q000097:blood / Q000627:therapeutic use; D006113:United Kingdom / Q000453:epidemiology; D014797:Vital Capacity
D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D013806:Theophylline